RIMKLA: A Ribosomal Modification Protein Thatregulates Gene Expression in Eukaryotic Cells

Target Name: RIMKLA

NCBI ID: G284716

RIMKLA

RIMKLA: A Ribosomal Modification Protein Thatregulates Gene Expression in Eukaryotic Cells

Ribosomal modification protein (RMP) is a family of proteins that play a crucial role in the regulation of gene expression in eukaryotic cells. RMP is a modification protein that adds a specific modification to the ribosome, allowing it to recognize and bind mRNA for translation into the cytoplasm. RimK like family member A (RIMKLA) is a subfamily of RMP that is characterized by the presence of a specific protein domain called K-cal hydrophobic domain (K-CSD).

RIMKLA is a protein that is expressed in various cell types of the eukaryotic organisms, including bacteria, archaea, and eukaryotes. It is highly conserved across different species, and its function is highly conserved as well. RimKLA is involved in the regulation of gene expression in various cell types, and it is a potential drug target or biomarker.

The rimK family of proteins is a subfamily of the RMP family that is characterized by the presence of a specific protein domain called K-cal hydrophobic domain (K-CSD). This domain is known to be involved in the regulation of protein stability and localization in the cytoplasm. RimKLA is a member of the rimK family and is composed of a unique nucleotide-binding oligomerization (NBO) domain, a K-CSD, and a C-terminal protein domain.

The NBO domain is a common protein domain that is found in various proteins, including RMP, and it is known to be involved in the regulation of protein stability and localization in the cytoplasm. The NBO domain is composed of a specific sequence that is involved in the regulation of protein stability and localization in the cytoplasm. The NBO domain is known to be involved in the regulation of protein stability by affecting the stability of the protein-ribosome complex, and it is also known to be involved in the regulation of protein localization in the cytoplasm by affecting the localization of the protein to the cytoplasmic side of the

Protein Name: Ribosomal Modification Protein RimK Like Family Member A

Functions: Catalyzes the synthesis of N-acetyl-L-aspartyl-L-glutamate (NAAG) and N-acetyl-L-aspartyl-L-glutamyl-L-glutamate

The "RIMKLA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RIMKLA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets